Diarrhea is a change in normal bowel movements characterized by increased frequency, water content or volume of stools.
Infectious diarrhea is diarrhea of infectious origin (bacteria, virus, protozoal, fungal) and is usually associated with symptoms of nausea and vomiting, abdominal cramps and fever.
Dysentery (invasive diarrhea) has the presence of visible blood in diarrheic stool.
A point-of-order test restriction algorithm for hospitalized adults with diarrhoea reduces bacterial stool cultures and ova and parasites testing, which results in substantial cost and time savings, according to a recent study.
Repeat 2-week rifaximin treatment course (up to three) appears
to be effective and safe for patients with relapsing symptoms of
diarrhoea-predominant irritable bowel syndrome (IBS-D), producing marked
improvements in abdominal pain and frequency of loose stools without
increasing the incidence of adverse events, according to the results of a
phase III trial.
RB Health is committed to support healthcare quality improvement through CME activities that help physicians stay updated with the latest developments in medicine. At the RB symposium held in Kuala Lumpur, two distinguished speakers gave their insights into the management of acid reflux and sore throat – two of the most common reasons for patients to visit their doctors.